HomeMarketsIndicesGilead Sciences (GILD) Hits 52-Week High
Gilead Sciences (GILD) Hits 52-Week High

Gilead Sciences (GILD) touched a new 52-week high today. Jenny Horne discusses this, as Morgan Stanley raised GILD's price target to $81 from $68. She also talks about how the E.U. granted expanded authorization for GILD HIV treatment in pediatric population. She then goes over other notable health care stocks hitting 52-week highs such as LLY, MRK, and BMY. Tune in to find out more about the stock market today.

Market On Close

02 Dec 2022

ON AIR
4:00 pm
Trading 360
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
ON AIR
4:00 pm
Trading 360
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US